Edition:
India

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

2.29USD
22 Jun 2018
Change (% chg)

$-0.10 (-4.18%)
Prev Close
$2.39
Open
$2.40
Day's High
$2.40
Day's Low
$2.27
Volume
34,208
Avg. Vol
13,123
52-wk High
$79.05
52-wk Low
$2.12

Latest Key Developments (Source: Significant Developments)

Reshape Lifesciences Says Reshape Balloon Granted Registration By National Health Regulation Authority In Kingdom Of Bahrain
Tuesday, 24 Apr 2018 

April 24 (Reuters) - ReShape Lifesciences Inc ::RESHAPE LIFESCIENCES INC - RESHAPE BALLOON GRANTED REGISTRATION BY NATIONAL HEALTH REGULATION AUTHORITY IN KINGDOM OF BAHRAIN.RESHAPE LIFESCIENCES INC - HAS SIGNED A DISTRIBUTION AGREEMENT WITH YOUSUF MAHMOOD HUSAIN CO W.L.L. OF BAHRAIN.  Full Article

SVLSF IV Reports 14 Pct Passive Stake In Reshape Lifesciences
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Reshape Lifesciences Inc ::SVLSF IV, LLC REPORTS 14 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES AS OF DEC 19 - SEC FILING.  Full Article

Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Reshape Lifesciences Inc ::RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​.  Full Article

Reshape Lifesciences qtrly loss per share $1.06‍​
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - Reshape Lifesciences Inc ::Reshape Lifesciences announces third quarter 2017 financial results.Q3 revenue $360,000.Reshape Lifesciences Inc - qtrly loss per share $1.06‍​.  Full Article

CVI Investments Inc reports 9.9 pct passive stake in Enteromedics Inc
Friday, 26 Aug 2016 

: CVI Investments Inc reports 9.9 pct passive stake in enteromedics inc, as of August 18, 2016 - Sec Filing Source - http://bit.ly/2cetnP4 Further company coverage: [ETRM.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Enteromedics Q2 loss per share $0.49
Thursday, 4 Aug 2016 

Enteromedics Inc : Enteromedics reports second quarter 2016 financial results . Q2 loss per share $0.49 .Q2 sales $276,000.  Full Article

EnteroMedics says CFP Greg Lea to retire effective as of October 1, 2016
Thursday, 7 Jul 2016 

Enteromedics Inc :On june 30, greg lea, co's cfo said intends to retire and leave his position with company effective as of october 1, 2016 - sec filing.  Full Article

BRIEF-Reshape Lifesciences Files For Mixed Shelf Of Up To $125 Mln

* RESHAPE LIFESCIENCES FILES FOR MIXED SHELF OF UP TO $125 MILLION - SEC FILING Source text: (https://bit.ly/2Ljt5n1) Further company coverage: